<DOC>
	<DOCNO>NCT03043508</DOCNO>
	<brief_summary>OBJECTIVES : The primary objective study evaluate effect estrogen development PNET MEN1 patient . The secondary objective evaluate overall survival disease specific survival patient confirm MEN1 without PNET pancreatic neuroendocrine tumor relation hormone status . The secondary objective evaluate clinicopathologic feature relation hormone status .</brief_summary>
	<brief_title>Overall Disease Specific Survival Patients With Confirmed MEN1 With Without PNET ( Pancreatic Neuroendocrine Tumors )</brief_title>
	<detailed_description>Retrospective review prospectively maintain MEN1 database . The patient cohort consist patient confirm MEN1 without PNET include database . The database review obtain patient disease characteristic , laboratory value , image result , hormone parameter ( menopausal status , bioidentical hormone use , oral contraception use , gestational status diagnosis prolactinoma ) vital status . For prospective portion study , investigator want see impact estrogen PNET form progression , would like use two equation ass estrogen exposure , investigator collect information menopause , menarche , breast feed , HRT , OCP use pregnancy . To end , investigator contact female patient database still live , obtain verbal informed consent send email questionnaire regard pregnancy hormone use history .</detailed_description>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Adenoma , Islet Cell</mesh_term>
	<mesh_term>Multiple Endocrine Neoplasia Type 1</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>1 . The patient cohort study consist patient within prospectively maintain MEN1 database within Department Surgical Oncology University Texas MD Anderson Cancer Center . 2 . Patients diagnosis MEN1 without PNET base mutational analysis define clinical criterion consider . 3 . All patient hormone status variable survival data available include . 1 . Due nature question include prospective estrogen questionnaire , female patient verbally consent receive questionnaire obtain prospective data .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Genetic mutation</keyword>
	<keyword>MEN1</keyword>
	<keyword>Pancreatic neuroendocrine tumor</keyword>
	<keyword>PNET</keyword>
	<keyword>Chart review</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Survey</keyword>
</DOC>